187 related articles for article (PubMed ID: 33430806)
21. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.
Rane S; Owen J; Hippe DS; Cholerton B; Zabetian CP; Montine T; Grabowski TJ
J Neuroimaging; 2020 Nov; 30(6):843-850. PubMed ID: 32937003
[TBL] [Abstract][Full Text] [Related]
22. Correlation between enlarged perivascular space and brain white matter hyperintensities in patients with recent small subcortical infarct.
Jian X; Xu F; Yang M; Zhang M; Yun W
Brain Behav; 2023 Sep; 13(9):e3168. PubMed ID: 37464257
[TBL] [Abstract][Full Text] [Related]
23. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage.
Agosta F; Canu E; Stefanova E; Sarro L; Tomić A; Špica V; Comi G; Kostić VS; Filippi M
Hum Brain Mapp; 2014 May; 35(5):1921-9. PubMed ID: 23843285
[TBL] [Abstract][Full Text] [Related]
24. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
[TBL] [Abstract][Full Text] [Related]
25. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
Hall JM; Lewis SJG
Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
[TBL] [Abstract][Full Text] [Related]
26. Interaction of systemic oxidative stress and mesial temporal network degeneration in Parkinson's disease with and without cognitive impairment.
Chiang PL; Chen HL; Lu CH; Chen YS; Chou KH; Hsu TW; Chen MH; Tsai NW; Li SH; Lin WC
J Neuroinflammation; 2018 Sep; 15(1):281. PubMed ID: 30257698
[TBL] [Abstract][Full Text] [Related]
27. Associations between microstructural tissue changes, white matter hyperintensity severity, and cognitive impairment: an intravoxel incoherent motion imaging study.
Lin H; Dai X; Su J; Yang S; Zheng Y; Ma M; Yu S
Front Aging Neurosci; 2023; 15():1258105. PubMed ID: 38094505
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
[TBL] [Abstract][Full Text] [Related]
29. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
30. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
[TBL] [Abstract][Full Text] [Related]
31. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
[TBL] [Abstract][Full Text] [Related]
32. Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
Park M; Baik K; Lee YG; Kang SW; Jung JH; Jeong SH; Lee PH; Sohn YH; Ye BS
J Alzheimers Dis; 2021; 83(2):545-556. PubMed ID: 34366356
[TBL] [Abstract][Full Text] [Related]
33. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
[TBL] [Abstract][Full Text] [Related]
34. White matter hyperintensities mediate the association between frailty and cognitive impairment in moyamoya disease.
Du J; Qu C; Xu Z; Liu Z; Lv M; Wang D; Wei W; Duan Y; Shen J
Clin Neurol Neurosurg; 2024 May; 240():108283. PubMed ID: 38608350
[TBL] [Abstract][Full Text] [Related]
35. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
[TBL] [Abstract][Full Text] [Related]
36. Association of cerebral white matter lesions with cognitive function and mood in Japanese elderly people: a population-based study.
Yamawaki M; Wada-Isoe K; Yamamoto M; Nakashita S; Uemura Y; Takahashi Y; Nakayama T; Nakashima K
Brain Behav; 2015 Mar; 5(3):e00315. PubMed ID: 25798332
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent cognitive and affective differences in Alzheimer's and Parkinson's diseases in relation to MRI findings.
Tokuchi R; Hishikawa N; Sato K; Hatanaka N; Fukui Y; Takemoto M; Ohta Y; Yamashita T; Abe K
J Neurol Sci; 2016 Jun; 365():3-8. PubMed ID: 27206864
[TBL] [Abstract][Full Text] [Related]
38. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
[TBL] [Abstract][Full Text] [Related]
39. White Matter Hyperintensity Associations with Cerebral Blood Flow in Elderly Subjects Stratified by Cerebrovascular Risk.
Bahrani AA; Powell DK; Yu G; Johnson ES; Jicha GA; Smith CD
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):779-786. PubMed ID: 28063772
[TBL] [Abstract][Full Text] [Related]
40. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
